Komori
Presentation materials for financial results7071Amvis Holdings,Inc.Information and Communications, Services and Others

2023年９月期上半期　決算説明会資料

2023年9月期上半期は、施設数・定員数の増加を背景に売上高147.4億円、営業利益39.3億円となり、通期予想に対しておおむね計画どおり進捗しました。今後は首都圏での開設を加速し、2024年7月に大阪府豊中市へ初進出する計画を示しています。

Worth reading
60In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
39.3
億円（上半期営業利益）
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Presentation materials for financial results2023年9月期 上半期11 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales147.4 Hundreds of millions of yen+41.9%
Operating profit39.3 Hundreds of millions of yen+36.5%
Net income30.6 Hundreds of millions of yen+54.2%
Operating profit margin26.7%（前年同期比：1.1ポイント低下）
Results for the three months of the current quarter
Net Sales
First quarter
¥7,259 million
Second quarter
¥7,482 million
Operating profit
First quarter
¥1,986 million
Second quarter
¥1,950 million
Profit attributable to owners of the parent
First quarter
¥1,398 million
Second quarter
¥1,664 million
Full-year earnings forecast
Net Sales
306.8 Hundreds of millions of yen
Operating profit
78.7 Hundreds of millions of yen
EBITDA
91.16 Hundreds of millions of yen
Profit attributable to owners of the parent
54 Hundreds of millions of yen
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales48.0%
Operating profit50.0%
Profit attributable to owners of the parent56.7%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
概ね想定通りの順調な進捗
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • 施設数・定員数の増加
  • 既存施設の高稼働率・新規施設の立ち上がり
  • インフレによる木材・エネルギー資源・施設用品への影響
  • 医心館四日市の譲渡に伴う特別利益4 Hundreds of millions of yen
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • 既存施設の安定稼働率
    Figures82～85%
  • 平均定員数
    Figures50名程度
  • 年間のがん患者受入れ数
    Figures～5,000人
  • 開設後の単月黒字化
    Figures4～6か月
  • 開設後の累積黒字化
    Figures10～12か月
  • Investment recovery
    FiguresWithin 5 years
New initiatives
  • Change in listed market segment to the TSE Prime Market
  • 2024年7月の医心館豊中開設による関西圏への初進出
  • 首都圏でのドミナント展開加速
  • 医心館四日市の他事業者への譲渡
Key KPIsA metric the company considers important as a management benchmark.
  • 既存施設の稼働率87.5 %
  • 新規施設の稼働率61.7 %
  • Number of facilities65 Facility
  • Capacity3,193 People
    Year on year against the same period last year約33%増
  • 上半期新規開設数8 Facility
Medium-term management plan targets
Plan nameAmvis 2025
Target fiscal yearFiscal year ended September 2025
Number of facilities127施設
Capacity6,328名
Net Sales523.6億円
Operating profit122.9億円
Net income for the current fiscal year83.3億円
Financial targets
Equity ratio当社目安30%以上、23年3月末実績48.7%
Market Size / Share
  • 年間のがん患者数約40万人
  • 医心館の年間受入れがん患者数～5,000人
  • 国内全体に占める医心館受入れの割合Approximately 1%
Number of stores and locations
End of period65 Facility
Openings and closures during the period上半期に8施設を新規開設、医心館四日市を譲渡。23年3月末時点で65施設
Capital expenditures
¥5,310 millions purchases of property, plant and equipment
Annual Dividend
Annual Dividend3.00円/株
End of period3.00円/株
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period Covered2023年9月期 上半期
Net Sales147.4 Hundreds of millions of yen (YoY +41.9%)
Operating profit39.3 Hundreds of millions of yen (YoY +36.5%)
Net income30.6 Hundreds of millions of yen (YoY +54.2%)
Operating profit margin26.7%（前年同期比：1.1ポイント低下）
Results for the three months of the current quarterNet Sales First quarter ¥7,259 million / Second quarter ¥7,482 million / Operating profit First quarter ¥1,986 million / Second quarter ¥1,950 million / Profit attributable to owners of the parent First quarter ¥1,398 million / Second quarter ¥1,664 million
Full-year earnings forecastNet Sales 306.8 Hundreds of millions of yen / Operating profit 78.7 Hundreds of millions of yen / EBITDA 91.16 Hundreds of millions of yen / Profit attributable to owners of the parent 54 Hundreds of millions of yen
Progress against full-year forecastNet Sales 48.0% / Operating profit 50.0% / Profit attributable to owners of the parent 56.7%
Self-assessment against the plan概ね想定通りの順調な進捗
Breakdown of Factors Affecting the ChangeFactors 施設数・定員数の増加 / Amount Not disclosed, Factors 既存施設の高稼働率・新規施設の立ち上がり / Amount Not disclosed, Factors インフレによる木材・エネルギー資源・施設用品への影響 / Amount Not disclosed, Factors 医心館四日市の譲渡に伴う特別利益 / Amount 4 Hundreds of millions of yen
Key KPIsIndicator name 既存施設の稼働率 / Value 87.5 % / Year on year against the same period last year Not disclosed, Indicator name 新規施設の稼働率 / Value 61.7 % / Year on year against the same period last year Not disclosed, Indicator name Number of facilities / Value 65 Facility / Year on year against the same period last year Not disclosed, Indicator name Capacity / Value 3,193 People / Year on year against the same period last year 約33%増, Indicator name 上半期新規開設数 / Value 8 Facility / Year on year against the same period last year Not disclosed
Number of stores and locationsEnd of period 65 Facility / Openings and closures during the period 上半期に8施設を新規開設、医心館四日市を譲渡。23年3月末時点で65施設
Assumptions Underlying the Business OutlookItem 既存施設の安定稼働率 / Figures 82～85%, Item 平均定員数 / Figures 50名程度, Item 年間のがん患者受入れ数 / Figures ～5,000人, Item 開設後の単月黒字化 / Figures 4～6か月, Item 開設後の累積黒字化 / Figures 10～12か月, Item Investment recovery / Figures Within 5 years
Medium-term management plan targetsPlan name Amvis 2025 / Target fiscal year Fiscal year ended September 2025 / Number of facilities 127施設 / Capacity 6,328名 / Net Sales 523.6億円 / Operating profit 122.9億円 / Net income for the current fiscal year 83.3億円
Financial targetsEquity ratio 当社目安30%以上、23年3月末実績48.7%
Annual DividendAnnual Dividend 3.00円/株 / Interim Not disclosed / End of period 3.00円/株
Capital expenditures¥5,310 millions (purchases of property, plant and equipment)
Market Size / ShareIndicator 年間のがん患者数 / Value 約40万人, Indicator 医心館の年間受入れがん患者数 / Value ～5,000人, Indicator 国内全体に占める医心館受入れの割合 / Value Approximately 1%
New initiativesChange in listed market segment to the TSE Prime Market, 2024年7月の医心館豊中開設による関西圏への初進出, 首都圏でのドミナント展開加速, 医心館四日市の他事業者への譲渡
Items this document does not state (11)
Ordinary incomeGross Profit MarginSelling, general and administrative expensesSegment resultsUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookPayout ratioAcquisition of treasury sharesOrders received and order backlogKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

施設数・定員数の増加と、既存施設の高い稼働率、新規施設の順調な立ち上がりが主な理由です。一方、木材・エネルギー資源・施設用品などはインフレの影響を受けています。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
2023年９月期上半期　決算説明会資料 | Amvis Holdings,Inc. (7071) timely disclosure | Komori